|
Richard M. Haugen: Rick has a good understanding of the pharmaceutical business, especially ophthalmics. He was the Chief Operating Officer and on the Board of Directors at Allergan a dominant company in the global ophthalmic pharmaceuticals business. Currently, Rick is the President of Newport Assets, Inc., an investment management company in California. Prior to this he was the President and CEO for Amylin Pharmaceuticals in San Diego, CA. Rick has a MBA in Finance from the University of Southern California. | 